Intellectual Property Magazine
Regeneron; Pfizer hit with Covid-19 therapeutic suits
‘Gold standard’ reagent technology used totreat Covid-19 subject of suit against pharmagiants
Ben Wodecki
A San-Diego based therapeutics firm is suing Regeneron,Pfizer and BioNTech over the alleged infringements of a reagent used
intherapeutics aimed at fighting Covid-19.